Session Details
[28-53-am]Clinical Pharmacy 12, Pharmacotherapies (Basics/Clinical)
Sat. Mar 28, 2026 9:30 AM - 11:30 AM JST
Sat. Mar 28, 2026 12:30 AM - 2:30 AM UTC
Sat. Mar 28, 2026 12:30 AM - 2:30 AM UTC
Room 53 (B306, Bldg. 1, Area 2 [3F])
Discusser: Hiroshi Takane, Nakamura Tsutomu
[28-53-am-01]In vitro investigation of BDNF upregulation by regional specialty citrus as potential therapeutic candidates for depression
○Nanami Kodama1, Kensuke Nakajima1, Masatsugu Ohgami1, Shigeru Oiso1,2 (1. Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University, 2. Graduate School of Pharmaceutical Sciences, Nagasaki International University)
[28-53-am-02]Evaluation of the additive effects of anticholinergic burden scores based on functional anticholinergic activity
○Aya Niki1, Kana Maruyama-Fumoto1, Shizuo Yamada2, Kazumasa Shinozuka1, Satomi Kagota1 (1. Dept. Pharmacol. II, Sch. Pharm. & Pharmaceu. Sci., Mukogawa Women’s Univ., 2. Ctr. Pharma-Food Res., Grad. Sch. Pharmaceu. Sci., Univ. Shizuoka)
[28-53-am-03]Degradation of Ikaros via E3 ubiquitin ligase X by DNA demethylating agents is a potential therapeutic target for MM
○yuta yamamoto1,2, Hiroshi Ureshino2, Moe Kawasaki2,3, Keisuke Kidoguchi1,2, Mai Fujita1,2, Ryo Yanagiya1,2, Shinya Kimura1,2 (1. Dept. Hematol., Saga Univ., 2. Dept. Pharm. Sci., Saga Univ., 3. OHARA Pharm. Co., Ltd.)
[28-53-am-04S]Comparison of cognitive function assessed by psychomotor function tests in patients with psychiatric disorders
○Yuma Shimizu1, Junichi Miyaura2,3, Ippei Takeuchi2,4, Masakazu Hatano2,5, Manako Hanya1,2, Hiroaki Mizutani3, Kiyoshi Fujita4, Nakao Iwata5, Hiroyuki Kamei1,2 (1. Grad. Sch. Pharm., Meijo Univ., 2. Fac. Pharm., Meijo Univ., 3. Yagoto Hospital, 4. Okehazama Hospital Kokoro Care Center, 5. Sch. Medicine., Fujita Health Univ.)
[28-53-am-05S]Cytotoxicity caused by extravasation of saccharated ferric oxide
○Yuta Ashizawa1, Mai Fujiwara1, Yusuke Naito1, Masaki Takaishi1, Akio Kobayashi1 (1. Pharm. Sci., IUHW.)
[28-53-am-06S]Cytotoxicity of dobutamine on human skin fibroblasts (SF-TY) cells
○Yusuke Naito1, Mai Fujiwara1, Yuta Ashizawa1, Masaki Takaishi1, Akio Kobayashi1 (1. Pharm. Sci., IUHW.)
[28-53-am-07S]Establishment of a method to prevent skin injury caused by etoposide-extravasation
○Mai Fujiwara1, Yuta Ashizawa1, Yusuke Naito1, Masaki Takaishi1, Akio Kobayashi1 (1. Pharm. Sci., IUHW.)
[28-53-am-08S]Exploration of the factor which influence to the change of lipid parameter caused by JAK inhibitor
○Ririko Hayashi1, Takuya Tsuchikawa2, Kotoe Inoue2, Tomoyuki Hirashita2, Takahiro Hayashi1 (1. College of Pharmacy, Kinjo Gakuin University, 2. Department of Pharmacy, Gifu Prefectural General Medical Center)
[28-53-am-09S]Research for vitamins that prevent Alzheimer's disease using Neprilysin activity .
○Serika Matsumoto1, Midori Suenaga1, Toshimi Nakamura1 (1. Tokushima Bunri University)
[28-53-am-10S]The Influence of Scutellaria baicalensis on drug-Induced pneumonitis caused by crude drugs
○Issei Ishinaka2, Syouki Nakahama2, Akiyoshi Kikkawa1, Hideaki Omatsu1, Tetuo Kaneko1, Kouji Kimura1, Msamitsu Nakajima2,3 (1. Sch. Pharm. Sci., Hiroshima international Univ., 2. Sch. Pharm. Sci., Hiroshima int'l Univ, Div., Jpn. Traditional Medicine, 3. NHO Kure Medical Center, Dept. of Jpn. Traditional Medicine)
